about
Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failureInhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migrationDetection of reactive oxygen species in isolated, perfused lungs by electron spin resonance spectroscopy.Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.Riociguat: Mode of action and clinical development in pulmonary hypertensionCirculating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary HypertensionBasic features of hypoxic pulmonary vasoconstriction in miceCongenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxiaIloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungsTherapeutic efficacy of azaindole-1 in experimental pulmonary hypertensionJumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungs.Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.Shroom expression is attenuated in pulmonary arterial hypertension.Fhl-1, a new key protein in pulmonary hypertension.The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension.Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.Oxidative injury of the pulmonary circulation in the perinatal period: Short- and long-term consequences for the human cardiopulmonary system.Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs.The Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary VasculatureHistological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease.Short-term improvement in pulmonary hemodynamics is strongly predictive of long-term survival in patients with pulmonary arterial hypertension.The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy.Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodelingProtective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertensionGlycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.Reversal of experimental pulmonary hypertension by PDGF inhibition.Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis.Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species.Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis.Effects of anti-inflammatory vagus nerve stimulation on the cerebral microcirculation in endotoxinemic rats.The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in ratsPhysiologic basis for the treatment of pulmonary hypertension.Cellular pathophysiology and therapy of pulmonary hypertension.
P50
Q21284417-3211A1F6-292C-4E18-8054-9EF0ACB5A91DQ21284504-93DE20EE-2BB2-42D9-ACEF-0B01A8153001Q24812224-CFDF7A35-9329-438B-8732-CDA3DFB13BD9Q24812364-69C80F82-B6B3-4BBC-B703-41219952400DQ24815216-C11CB90E-0B0B-4D0B-92BD-6874CF278A9BQ26748684-3CCE14E8-6044-41FC-B54F-E4CA57716593Q28109687-2D81523C-77A4-44B0-B159-6D24FDE51922Q28168498-9B25C458-6462-43CF-84B0-AD02A4818D9BQ28193126-54706638-E6CF-410E-B5CF-048C61CCCA10Q28218337-EF4A6D9B-A001-46E6-B486-05E86F11D787Q28284526-3504B31A-7293-4F34-B716-F463847716E2Q28507470-F61D6C41-F3A1-4580-8CDB-BC1625D57EE3Q32127934-7F7356FF-97BF-4DA9-9CF3-FC3C077B68E7Q33282243-F11A95E8-8BE3-4CD3-94BD-277BB8D35A5BQ33343409-F9CCE86D-8E77-4FB2-B3D4-5D1B8122E57EQ33363032-9D573560-9D32-41E7-9AE9-821B90D547EAQ33386662-A4D7B7D0-E666-4B14-AA89-89687F39C4B4Q33393513-09676870-29AE-4BCF-985C-5EF05DC45B4CQ33738656-82A1A16D-FC7F-480D-9551-3B7682952332Q33746190-F35EE35C-9B9B-4651-8784-8C9C0E8EB4ACQ33804336-D189BA36-4F94-40A0-8727-CE2DB9482BF1Q33805932-DAF7164D-59FD-46B3-9D4B-6FFD4510DBBCQ33806163-0DEC9E14-DD0E-4E99-A07E-115A6354B708Q33806178-633ECE59-9591-479A-BCFD-955E348A8041Q33814824-174D61E9-A80C-495E-9AB8-14AB46318C0AQ33824233-0EBCFC6B-95F4-45FC-96D2-7FFB7210436DQ33873485-88655EAA-33AB-4D89-8CFE-83D0D4098A2CQ33881508-1CBD6C5D-2BD2-4DD0-936B-1D21935B7670Q33886299-C223D607-800D-46D3-BE29-0AC7BF706F3BQ33895012-7F2AD540-151C-45D8-9A3B-8501AC6FD44FQ34025109-33DFB4FA-CEC8-4ED6-A395-45D14F5AFA10Q34048479-540D3F12-9572-4A63-8005-827C217621ADQ34056717-6D3F8E0A-35F7-4BEF-9666-F9ECD90B6BD5Q34150501-1C6FC89A-13C2-428E-8A35-E0D4114DAAB1Q34316590-370D837B-8E3C-49B7-BD27-4AB39AEC4A0BQ34332085-2B1962A2-6B82-49EE-A4E9-3B0A4520E479Q34351346-68E1F312-8B3E-4F97-B475-B9B92957B536Q34389618-630F66E2-08D0-49ED-9A9F-BE259EE47B53Q34440054-25211B8A-A10E-4739-BEB9-33919A1B08D6Q34468643-26E2805F-C63A-4C5C-A9DC-4629C1016E52
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ralph T Schermuly
@ast
Ralph T Schermuly
@en
Ralph T Schermuly
@es
Ralph T Schermuly
@nl
Ralph T Schermuly
@sl
type
label
Ralph T Schermuly
@ast
Ralph T Schermuly
@en
Ralph T Schermuly
@es
Ralph T Schermuly
@nl
Ralph T Schermuly
@sl
altLabel
Ralph Schermuly
@en
prefLabel
Ralph T Schermuly
@ast
Ralph T Schermuly
@en
Ralph T Schermuly
@es
Ralph T Schermuly
@nl
Ralph T Schermuly
@sl
P214
P244
P106
P21
P213
0000 0001 1542 9991
P214
P244
no2011019810
P31
P496
0000-0002-5167-6970
P735
P7859
lccn-no2011019810